P46353 8th Annual Biomanufacturing 2018
Download Brochure Request

Register your interest

Comments

Register your interest

Comments

8th Annual Biomanufacturing 2018

Gain insights from top CMOs and Pharma on their challenges, learnings and strategies to improve competitiveness in this evolving industry.

15 – 17 May 2018, Hilton Shanghai Hongqiao Hotel, China

Book Now Download Brochure

overview

Part of the Biopharma Development & Production Week (BDP), IBC’s 8th Annual Biomanufacturing Conference provides a timely platform for industry experts to have in-depth discussions on new biomanufacturing technologies, latest regulations, and ways to improve the speed, cost, quality of your process development and manufacturing efforts. Gain insights from top CMOs and Pharma on their challenges, learnings and strategies to improve competitiveness in this evolving industry.

Highlights

  • 300+ Companies, 70+ speakers, 60+ Sessions
  • Unparalleled learning and targeted networking across three (3) co-located events
  • Discover application of new disruptive technologies and how they are improving process development
  • Explore trends in facilities of the future and how to implement them
  • Challenges and opportunities in the increasing use of single use technologies
  • Learn from real world case studies on achieving operational, quality and cost effectiveness
  • CMO Selection and Oversight strategies
  • Preview latest equipment and technologies and hear from top vendors on how they are partnering with your peers

Part of

Biopharma Development & Production >>

Co-Located Events

Biosimilars Asia >>
Cell Line Development and Engineering >>
Biomanufacturing >>

agenda

9:00 am

Pall has built the capability to offer End 2 End solution for monoclonal antibody manufacturing, both in batch processing and in continuous processing. This workshop will help you to update the newest strategy to build a pilot or commercial facility for Mab manufacturing.

 

4:00 pm

End of workshop

8:00 am

Day 1 Main Conference Registration Opens and Morning Coffee

BIOPHARMA DEVELOPMENT AND PRODUCTION 2018 OPENING PLENARY SESSIONS

9:00 am

Chairperson’s Opening Remarks

9:10 am

  • Innovation in biopharma pipelines – what can we expect
  • Recent regulatory developments – obstacle or opportunity?
  • How digitalisation of BioPharma is creating new value propositions
  • Biomanufacturing market snapshot in China
  • Biosimilars market potential – what can we achieve?
  • New trends in cell line development

 

9:50 am

[Industry Address] Understanding the Investment Climate in Biopharma Industry – How is Market Responding to Inflow and Outflow of Investments?

Abrar Mir, Managing Partner, Quadria Capital Investment Management Pte Ltd, Singapore

10:20 am

Transforming BioPharma with Technology and Digitalisation

Wang Honglou, CIO, livzon Pharmaceutical Group

10:50 am

Morning Networking and Refreshment Break

END OF OPENING PLENARY AND BIOMANUFACTURING CONFERENCE COMMENCES

11:20 am

Chairperson’s Opening Remarks

11:25 am

  • General requirements for manufacturing of biotech products: current FDA guidances
  • What should be submitted in BLA for US FDA for biotech products including biosimilar products
  • FDA Pre-license inspection coverages: three objectives

11:55 am

  • How CMOs can step up to ensurequality compliance and stable supply chains
  • Opportunities with ‘Infrastructure’ improvement
  • Investments needed
  • Ket criteria to make the MAH regime work

More panelists to be confirmed

12:30 pm

Networking Lunch

CMO PARTNERSHIPS

1:30 pm

  • Biologics and antibodies in particular are thriving in market place
  • Process is part of biologics product definition
  • Quality of an IgG1 antibody is ultra-sensitive to manufacturing conditions
  • Careful control of process leads to high quality product

UTILITY EFFICENCY AND OPTIMIZATION

2:00 pm

  • The needs to optimize bioproduction and improve facility utilization
  • Modular continuous processing skids
  • Smart automation enable integrated continuous processing

2:30 pm

Case Study: High Productivity Downstream Process for mAb Mass Production

3:00 pm

Afternoon Teabreak

3:30 pm

Effect of Fully Continuous Process for Mab Manufacturing: Speed to Market and Cost Reduction

Noel Rob, Business Development Manager, Pall Life Sciences

4:00 pm

Efficacy of Insulation Systems in Aseptic areas and facilities: A Practical Guide to Facility Cost Reduction

David Sadler, President & CEO, Kunshan Zotek Kinglai Co. Ltd. U.K.

4:30 pm

Current Challenges of Biologics Manufacturing in China

Xu Wei, Vice President, Manufacturing , Innovent Biologics

5:00 pm

  • Technical perspective about ligand design, bead design and surface modification
  • Improving binding capacity and process robustness
  • Optimizing impurity removal, reducing process time

5:30 pm

Process and analytical Development to cGMP manufacturing and Scale up

Zack Zheng, Ph.D. VP of Process Development (Wuhan), JHL BioTech

6:00 pm

End of Main Conference Day One followed by Networking Cocktail

8:45 am

Day 2 Main Conference

8:50 am

Chairperson’s Opening Remarks

INNOVATIONS IN MANUFACTURING SCIENCE TECHNOLOGY

9:00 am

  • Racing to clinical trials is crucial for startup biotech survival.
  • CMC development is one of the most critical IND enabling deliverables.
  • Leverage phase- and region- appropriate strategies is the key to expedite CMC development and IND filings

9:20 am

Rapid and Robust Bacterial Endotoxin Detection

Wendy Chiang, Managing Director of Microbial Solutions, Greater China Region, Charles River Laboratories

9:50 am

Perspectives in Process Intensification for mAb Purification

Dr Yvan Ruland, Technology Manager Biopharma, Novasep

QUALITY COMPLIANCE AND SYSTEMS

10:20 am

Meeting the Quality and Compliance Requirements in Manufacturing Process

Joycelyn Kwek, Former Director, Quality Assurance, Amgen Singapore

10:40 am

Morning Tea Break

11:10 am

Boehringer-Ingelheim, bring your biologics to the clinic and market

Dr. Bin Wang, Head of Business Development, Boehringer Ingelheim Biopharmaceuticals China

11:40 am

  • Risk based microbial control strategy
  • Identification and implementation of measures to control the sources of microorganisms and the conditions that promote their survival and persistence
  • Monitoring of the facility, equipment, personnel, process, product and their interactions
  • Intervening or remediating when there is a drift from established controls

12:10 pm

Networking Lunch

FACILITIES AS COMPETITIVE ADVANTAGE

1:10 pm

Strategic Practice in Building Quality Management Systems (QMS) in China Facilities

Dr. Dennis Yu Xia, Vice President of Manufacturing and Quality, Akeso Bio

1:40 pm

  • Meeting WHO PQ requirement
  • Streamlining facility concept design to engineering design
  • Building out facility in a quick and efficient way

2:10 pm

Smart Automation: Achieving Increased Productivity through Optimized Asset Utilisation

Hai Bin Wang, Senior Vice President, Director, Biologic, Zhejiang Hisun Pharmaceutical Co Ltd

2:40 pm

Design, Construction and Commissioning Biomanufacturing Facilities

Yifang Wu, President, Wanbang Biopharmaceuticals Co., Ltd

3:00 pm

Innovative Laboratories Design Trends and Applications

Grace Zheng, Head of Bioprocess, ZaiLab, Ltd.

3:40 pm

Afternoon Networking and Refreshment Break

BIOPHARMA DEVELOPMENT & PRODUCTION 2018 CLOSING PLENARY SESSIONS

4:20 pm

  • Enabling drivers of innovation in China
  • Consolidation of local players
  • Shifting investment from manufacturing focus to innovative portfolios
  • Adopting technologies that enable the potential in manufacturing, cell development and similarity
  • Attracting the right talent

5:00 pm

Chairperson’s Summary of the Day and End of Conference

pricing

Packages Price
2 Day ConferenceUS $1895US $1695Early BirdEarly Bird
Group Rate (2 or more delegates)US $1495Early Bird
Group Rate (4 or more delegates)US $1295Early Bird
Extras Price
Pre Conference Workshop US $300
Packages Price
2 Day ConferenceUS $977US $827Early BirdEarly Bird
Group Rate (2 or more delegates)US $752Early Bird
Group Rate (4 or more delegates)US $676Early Bird
Extras Price
Pre Conference Workshop US $150

 

  • Multiple Bookings Discount pricing is applicable to groups of 2 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)

Sponsorship

Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

speakers

Noel Rob

Business Development Manager, Pall Life Sciences

Xu Wei

Vice President, Manufacturing , Innovent Biologics

Abrar Mir

Managing Partner, Quadria Capital Investment Management Pte Ltd, Singapore

Wang Honglou

CIO, livzon Pharmaceutical Group

Zhihao (Peter) Qiu

Branch Chief, Division of Inspectional Assessment, Office of Process and Facilities, Office of Pharmaceutical Quality, CDER, FDA, U.S.

Jian Dong

VP & Site Head of Manufacturing, Wuxi AppTec

Zack Zheng

Ph.D. VP of Process Development (Wuhan), JHL BioTech

Dr. Jinyou Zhang

Senior Vice President/Head, Bio development and manufacturing, BeiGene Beijing Co Ltd

Barbara A. Paldus, Ph.D.

Vice President & General Manager, Finesse, part of Thermo Fisher Scientific

David Sadler

President & CEO, Kunshan Zotek Kinglai Co. Ltd. U.K.

Senior representative, JSR Life Sciences INC., U.S

Bo Qi

M.Sc. Vice President Head of CMC General Manager, Generon Beijing

Wendy Chiang

Managing Director of Microbial Solutions, Greater China Region, Charles River Laboratories

Dr Yvan Ruland

Technology Manager Biopharma, Novasep

Joycelyn Kwek

Former Director, Quality Assurance, Amgen Singapore

Dr. Bin Wang

Head of Business Development, Boehringer Ingelheim Biopharmaceuticals China

Hui Cai

Head of QC Laboratory 2 & Head of Microbial Control Team, WuXi Biologics

Dr. Dennis Yu Xia

Vice President of Manufacturing and Quality, Akeso Bio

Dr. John Zeng

Executive Vice President, Bioprocess Development & Pilot Plant Manufacturing, Shanghai Zerun Biotech Co Ltd

Hai Bin Wang

Senior Vice President, Director, Biologic, Zhejiang Hisun Pharmaceutical Co Ltd

Yifang Wu

President, Wanbang Biopharmaceuticals Co., Ltd

Grace Zheng

Head of Bioprocess, ZaiLab, Ltd.

Alvin Luk

Senior Vice President and Chief Medical Officer - Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China

when & where

15 - 17 May 2018

Hilton Shanghai Hongqiao
No. 1116 Hong Song East Rd, Shanghai, 201103, China
Tel: +86-21-3323 6666

contact

Still have a question?

Speaking Opportunities
Sophia Zhao
+65-6508 2491
 
sophia.zhao@ibcasia.com.sg

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Yvonne.Leong@ibcasia.com.sg

Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg

STAY UPDATED ON OUR NEWS & EVENTS

IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more